{"id":217137,"date":"2017-06-06T18:05:33","date_gmt":"2017-06-06T22:05:33","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/valeant-there-is-significant-bankruptcy-risk-here-seeking-alpha.php"},"modified":"2017-06-06T18:05:33","modified_gmt":"2017-06-06T22:05:33","slug":"valeant-there-is-significant-bankruptcy-risk-here-seeking-alpha","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/bankruptcy\/valeant-there-is-significant-bankruptcy-risk-here-seeking-alpha.php","title":{"rendered":"Valeant: There Is Significant Bankruptcy Risk Here &#8211; Seeking Alpha"},"content":{"rendered":"<p><p>    Article Thesis  <\/p>\n<p>    Valeant's (NYSE:VRX)    huge net debt position and worsening operational performance    mean that there is non-negligible credit risk for Valeant. It    thus seems best to avoid the company's shares, especially since    there is no catalyst in sight that could allow for an ongoing    share price recovery.  <\/p>\n<\/p>\n<p>    Rationale  <\/p>\n<p>    Valeant has been a high flyer for years, with its share price    seemingly growing endlessly  until, at one point, it didn't.  <\/p>\n<p>    Valeant's fall, which decimated 95% of the company's share    price, began in the second half of 2015, when the company's    non-GAAP earnings story began to show some cracks. In the    fourth quarter the company reported GAAP losses of $0.98 per    share, whilst still claiming underlying earnings power    (non-GAAP earnings) of $2.50 per share. The market since got    wary of Valeant's adjusted earnings numbers, and rightfully so,    the company has, however, reverted its use of big adjustments    since, and GAAP number and non-GAAP numbers are now more in    line with each other.  <\/p>\n<p>    In the most recent quarter Valeant's GAAP results were actually    better than the company's non-GAAP numbers:  <\/p>\n<\/p>\n<p>    As we can see, GAAP net income of $628 million is much higher    than the non-GAAP bottom line number -- which Valeant does not    include in its quarterly release. We can, however, calculate it    by using the EBITA number of $766 million and adjusting it for    interest expenses, taxes and amortization of intangible assets.  <\/p>\n<\/p>\n<p>    VRX    Net Interest Income (Quarterly) data by YCharts  <\/p>\n<p>    When we assume amortization costs to be zero, and calculate    with interest expenses of $470 million, we get to pre-tax    earnings of a little below $300 million, which, adjusted for    taxes, means adjusted net earnings of $180 million.  <\/p>\n<\/p>\n<p>    VRX    Effective Tax Rate (NYSE:TTM) data by YCharts  <\/p>\n<p>    When we calculate with amortization expenses of $500 million,    which is in line with the quarterly average over the last    years, we don't get to any net earnings, however -- pre-tax    losses would total $200 million quarterly.  <\/p>\n<p>    Valeant is in too much debt  <\/p>\n<p>    In order to determine the sustainability of Valeant's debt    pile, we should look at its debt to EBITDA ratio:  <\/p>\n<\/p>\n<p>    Valeant points out that its debt position has shrunk from $32.3    billion at the end of the first quarter of 2016 to $28.9    billion one year later, but that is only part of the story.  <\/p>\n<p>    Over the same twelve months, Valeant's adjusted EBITDA has    declined by $1.1 billion, which means the debt to EBITDA ratio    is now actually higher than it was one year ago: 6.95 versus    6.15, respectively.  <\/p>\n<p>    Valeant's earnings power is shrinking at a much faster pace    than its debt position, which means the debt pile is getting    ever less sustainable.  <\/p>\n<p>    When we annualize Q1's EBITDA of $860 million, we get to an    estimate of $3.4 billion in EBITDA this year -- which could    still be too high, as it does not account for further    deterioration in Valeant's earnings power. In this case the    debt to EBITDA multiple would stand at 8.4.  <\/p>\n<p>    What happens when this is combined with rising interest rates,    which makes Valeant's debt ever more expensive?  <\/p>\n<p>    The Federal Funds rate is expected to grow to 3.0% over the next 18 months, an increase of    2.1 percentage points from the current    level. If higher central interest rates are resulting in    likewise higher interest rates for Valeant, the company could    see its interest expenses rise by $610 million annually over    the next one and a half years.  <\/p>\n<p>    If, at the same time, Valeant's EBITDA continues to shrink at a    20% a year rate, the annual EBITDA run rate would total below    $3 billion by the end of 2018.  <\/p>\n<\/p>\n<p>    VRX Net    Interest Income (TTM) data by YCharts  <\/p>\n<p>    As Valeant's interest expenses already total $1.9 billion, the    total would stand at $2.5 billion -- barely covered by EBITDA.    This does not include the impact of Valeant's ever-increasing    debt to EBITDA ratio, which would likely push Valeant's    interest expenses even higher -- this only calculates for    sustained EBITDA declines and the increase in the Fed Funds    rate.  <\/p>\n<p>    It is difficult to forecast the additional impact of higher    interest expenses due to investors shying away from Valeant's    bonds if they are deemed too risky. But the fact that, even    when we do not account for that, Valeant could be in a position    where the company is just barely able to finance its interest    expenses in one and a half years is a good reason for investors    to think hard about whether it is a good idea to hold Valeant's    shares.  <\/p>\n<p>    The market cap has come down to a small level, and due to the    huge volatility in Valeant's share price, it is very possible    to make some short term gains. But in the long run, the outlook    is not positive, and when we look a couple of years into the    future, we see that Valeant could come into a position where it    is no longer able to finance its debt.  <\/p>\n<p>    I thus believe that it is best to stay away from this company's    shares.  <\/p>\n<p>    Takeaway  <\/p>\n<p>    Valeant's non-GAAP shenanigans have ended, and for the most    recent quarter it makes sense to look at the adjusted results.    These spell trouble, however, as the company's earnings power    is shrinking much faster than its debt levels.  <\/p>\n<p>    Add in Federal Funds rate hikes that push interest rates    higher, and the possibility of investors shying away from    Valeant's bonds (which would increase interest rates further),    and the risk for Valeant not being able to finance its debt any    longer in a couple of years is not negligible any more.  <\/p>\n<p>    Author's note: If you enjoyed this article and    would like to read more from me, you can hit the \"Follow\"    button to get informed about new articles.  <\/p>\n<p>    Disclosure: I\/we have no positions in any stocks    mentioned, and no plans to initiate any positions within the    next 72 hours.  <\/p>\n<p>    I wrote this article myself,    and it expresses my own opinions. I am not receiving    compensation for it (other than from Seeking Alpha). I have no    business relationship with any company whose stock is mentioned    in this article.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>More: <\/p>\n<p><a target=\"_blank\" rel=\"nofollow\" href=\"https:\/\/seekingalpha.com\/article\/4079081-valeant-significant-bankruptcy-risk\" title=\"Valeant: There Is Significant Bankruptcy Risk Here - Seeking Alpha\">Valeant: There Is Significant Bankruptcy Risk Here - Seeking Alpha<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Article Thesis Valeant's (NYSE:VRX) huge net debt position and worsening operational performance mean that there is non-negligible credit risk for Valeant. It thus seems best to avoid the company's shares, especially since there is no catalyst in sight that could allow for an ongoing share price recovery. Rationale Valeant has been a high flyer for years, with its share price seemingly growing endlessly until, at one point, it didn't.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/bankruptcy\/valeant-there-is-significant-bankruptcy-risk-here-seeking-alpha.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[494458],"tags":[],"class_list":["post-217137","post","type-post","status-publish","format-standard","hentry","category-bankruptcy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/217137"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=217137"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/217137\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=217137"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=217137"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=217137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}